AARD·002942100·US·equity·Healthcare - Biotechnology-13D/G
AARD (Aardvark Therapeutics, Inc.) is held by 44 institutional investors as of Q4 2025. Largest holders: CITADEL ADVISORS LLC ($16.9M), BlackRock, Inc. ($10.3M), VANGUARD GROUP INC ($9.4M). Net institutional sentiment: Bullish.
See how AARD's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer